Annals of oncology |
Clinical outcomes of elderly patients receiving neoadjuvant chemoradiation for locally advanced rectal cancer |
Jan. 16 |
2 ♥ |
Cancer colorectal (CCR) |
Annals of oncology |
Prognostic and predictive value of primary tumour side in patients with RAS wild-type metastatic colorectal cancer treated with chemotherapy and EGFR directed antibodies in six randomised trials |
aoû. 17 |
2 ♥ |
Cancer colorectal (CCR) |
Annals of oncology |
A randomized clinical trial of neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for cancer of the oesophagus or gastro-oesophageal junction. |
mai. 16 |
2 ♥ |
Cancers autres (hors CCR et CHC), Oesophage/Estomac |
Annals of oncology |
Sunitinib in Pancreatic Neuroendocrine Tumors: Updated Progression-Free Survival and Final Overall Survival From a Phase III Randomized Study |
nov. 16 |
2 ♥ |
Cancers autres |
Annals of oncology |
Investigating the poor outcomes of BRAF-mutant advanced colorectal cancer: Analysis from 2530 patients in randomised clinical trials. |
mar. 17 |
2 ♥ |
Cancer colorectal (CCR) |
Annals of oncology |
Cetuximab continuation after first progression in metastatic colorectal cancer (CAPRI-GOIM): a randomized phase II trial of FOLFOX plus cetuximab versus FOLFOX |
juin. 16 |
2 ♥ |
Cancer colorectal (CCR) |
Annals of oncology |
Maintenance treatment with capecitabine and bevacizumab versus observation in metastatic colorectal cancer: updated results and molecular subgroup analyses of the phase 3 CAIRO3 study. |
sep. 17 |
2 ♥ |
Cancers autres (hors CCR et CHC) |
Annals of oncology |
Clinical utility of circulating DNA analysis for rapid detection of actionable mutations to select metastatic colorectal patients for anti-EGFR treatment. |
sep. 17 |
3 ♥ |
Cancer colorectal (CCR) |
British journal of Cancer |
Can we classify ampullary tumours better? Clinical, pathological and molecular features. Results of an AGEO study |
avr. 19 |
2 ♥ |
Cancers autres (hors CCR et CHC) |
British journal of Cancer |
Serum LDH predicts benefit from bevacizumab beyond progression in metastatic colorectal cancer |
Jan. 17 |
2 ♥ |
Cancer colorectal |
British journal of Cancer |
Gemcitabine plus platinum-based chemotherapy for first-line treatment of hepatocholangiocarcinoma: an AGEO French multicentre retrospective study. |
fév. 18 |
2 ♥ |
Cancers autres (hors CCR et CHC) |
British journal of Cancer |
Patterns of progression, treatment of progressive disease and post-progression survival in the New EPOC study |
aoû. 16 |
1 ♥ |
Cancer colorectal (CCR) |
British journal of Cancer |
Sorafenib alone vs. sorafenib plus GEMOX as 1st-line treatment for advanced HCC: the phase II randomised PRODIGE 10 trial |
avr. 19 |
1 ♥ |
Carcinome hépatocellulaire (CHC) |
British journal of Cancer |
The impact of age on complications, survival, and cause of death following colon cancer surgery |
Jan. 17 |
3 ♥ |
Cancer colorectal (CCR) |
British journal of Cancer |
A meta-analysis comparing the risk of metastases in patients with rectal cancer and MRI-detected extramural vascular invasion (mrEMVI) vs mrEMVI-negative cases |
juin. 17 |
2 ♥ |
Cancers autres (hors CCR et CHC) |
British journal of Cancer |
Pharmacogenetic determinants of outcomes on triplet hepatic artery infusion and intravenous cetuximab for liver metastases from colorectal cancer (European trial OPTILIV, NCT00852228) |
sep. 17 |
2 ♥ |
Cancer colorectal (CCR) |
British journal of Cancer |
Characterisation of PD-L1-positive subsets of microsatellite-unstable colorectal cancers |
aoû. 16 |
2 ♥ |
Cancer colorectal (CCR) |
British journal of Cancer |
Determination of an optimal response cut-off able to predict progression-free survival in patients with well-differentiated advanced pancreatic neuroendocrine tumours treated with sunitinib: an alternative to the current RECIST-defined response. |
Jan. 18 |
3 ♥ |
Cancers autres (hors CCR et CHC) |
British journal of Cancer |
Effect of low-dose aspirin use on survival of patients with gastrointestinal malignancies; an observational study |
Jan. 17 |
3 ♥ |
Cancer colorectal (CCR) |
British journal of Cancer |
Nomogram-based prediction of survival in patients with advanced oesophagogastric adenocarcinoma receiving first-line chemotherapy: a multicenter prospective study in the era of trastuzumab |
juin. 17 |
1 ♥ |
Cancers autres (hors CCR et CHC) |
British journal of Cancer |
Diagnostic value of CA19.9, circulating tumour DNA and circulating tumour cells in patients with solid pancreatic tumours |
sep. 17 |
4 ♥ |
Cancers autres (hors CCR et CHC) |
British journal of Cancer |
The oral VEGF receptor tyrosine kinase inhibitor pazopanib in combination with the MEK inhibitor trametinib in advanced cholangiocarcinoma |
mai. 17 |
2 ♥ |
Cancers autres (hors CCR et CHC) |
British journal of Cancer |
Biomarker analyses in REGARD gastric/GEJ carcinoma patients treated with VEGFR2-targeted antibody ramucirumab |
oct. 16 |
1 ♥ |
Cancer colorectal (CCR) |
British journal of Cancer |
Prognostic nomogram and score to predict overall survival in locally advanced untreated pancreatic cancer (PROLAP) |
juil. 16 |
2 ♥ |
Cancers autres (hors CCR et CHC), Pancréas/Voies biliaires |
British journal of Cancer |
Phase 1B trial of Nab-paclitaxel plus gemcitabine, capecitabine, and cisplatin (PAXG regimen) in patients with unresectable or borderline resectable pancreatic adenocarcinoma |
juil. 16 |
2 ♥ |
Cancers autres (hors CCR et CHC), Pancréas/Voies biliaires |